Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Opening Hours
Collections
Help Via Email

Electronic Information Resources

Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review

详细信息查看全文

作者：Wenxiao Jiang^a ; ^{jiangwenxiao@163.com" class="auth_mail} ; Qi Shen^a ; ^{wzlunwen@163.com" class="auth_mail} ; Miaomiao Chen^a ; ^{mmcwzmc@163.com" class="auth_mail} ; Ying Wang^a ; ^{wy815161578@163.com" class="auth_mail} ; Qingfeng Zhou^a ; ^{mickeyzqf@126.com" class="auth_mail} ; Xuejie Zhu^b ; ^{zxj1022@163.com" class="auth_mail} ; Xueqiong Zhu^a ; ^{zjwzzxq@163.com" class="auth_mail}
关键词：Levonorgestrel-releasing intrauterine systems ; Uterine leiomyoma ; Uterine volume ; Leiomyoma volume ; Endometrial thickness
刊名：Steroids
出版年：August 2014
年：2014
卷：86
期：Complete
页码：69-78
全文大小：530 K

文摘

•: The efficacy and safety of LNG-IUSs use in women with symptomatic uterine leiomyoma.
•: LNG-IUSs could decrease uterine volume and endometrial thickness.
•: LNG-IUSs could reduce menstrual blood loss.
•: LNG-IUS expulsion was related to leiomyoma size.
•: LNG-IUSs have no adverse effects on the ovarian function except for ovarian cysts.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.